Through the progress of scientific knowledge the Vero cell line was considered to be a suitable alternative cell substrate for the industrial production of Polio Virus. Using microcarrier culture, more than 10(12) cells could be obtained weekly for virus inoculation. The virus yield is around 60 D units/ml for type I; 20 D units/ml for type II, and 50 D units/ml for type III.

Download full-text PDF

Source

Publication Analysis

Top Keywords

units/ml type
12
microcarrier culture
8
polio virus
8
type units/ml
8
litre scale
4
scale microcarrier
4
culture vero
4
vero cells
4
cells killed
4
killed polio
4

Similar Publications

Donor hepatitis C status is not associated with an increased risk of acute rejection in kidney transplantation.

Surg Pract Sci

March 2024

Department of Surgery, Division of Multiorgan Transplant and Hepatobiliary Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, 77555-0655, USA.

Introduction: In renal transplantation, donor hepatitis C virus (HCV) status is crucial to consider when selecting a recipient given the high likelihood of transmission. We analyzed the effect of donor HCV status on post-renal transplant rejection and virologic infectious outcomes using electronic health record data from multiple US health care organizations.

Methods: Using real world data from electronic health records of renal transplant recipients, a propensity score-matched case-control study of one-year renal transplant outcomes was conducted on cohorts of HCV-negative recipients who received an organ from an HCV-positive donor (HCV D+/R-) versus from an HCV-negative donor (HCV D-/R-).

View Article and Find Full Text PDF
Article Synopsis
  • TTP is a serious condition linked to low activity of the ADAMTS-13 enzyme, with traditional testing methods being slow and labor-intensive.
  • A new automated chemiluminescent enzyme immunoassay (CLEIA) has been developed, which is sensitive and quick, allowing results in just 17 minutes.
  • The CLEIA showed excellent agreement with conventional assays in accurately measuring ADAMTS-13 activity and detecting inhibitory antibodies, making it a reliable option for diagnosing and monitoring TTP in hospitals.
View Article and Find Full Text PDF

, an opportunistic pathogen toward aquatic organisms, was identified as the causative pathogen (isolate WH10) in diseased bronze gudgeon via bacterial isolation, and morphological, physiological, biochemical, and molecular characterization. WH10 exerted its pathogenicity via five virulence genes, including those encoding cytotoxic enterotoxins (act and alt), lipase (lip), a quorum sensing-controlled virulence factor (LuxS), and a Type III secretion system inner membrane component (ascV). WH10 was shown to be sensitive to compound sulfamethoxazoles, cefothiophene, doxycycline, and sulfamethoxazole.

View Article and Find Full Text PDF

Angiotensin II Type 2 Receptor Antibodies in Glomerular Diseases.

Arch Immunol Ther Exp (Warsz)

January 2024

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.

Article Synopsis
  • A study evaluated AT2R antibody concentrations in 136 patients with various glomerular diseases and compared them to a healthy control group.
  • Results showed that systemic lupus erythematosus patients had significantly higher AT2R antibody levels than controls, while other diseases did not show this difference.
  • Significant correlations between AT1R and AT2R antibodies were found in patients with membranous nephropathy, IgA nephropathy, and c-ANCA vasculitis, but no link was established between AT2R levels and the disease's clinical progression.
View Article and Find Full Text PDF

Aims/hypothesis: Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal the heterogeneity of the at-risk population by identifying clinically meaningful clusters are lacking. We aimed to identify and characterise clusters of islet autoantibody-positive individuals who share similar characteristics and type 1 diabetes risk.

Methods: We tested a novel outcome-guided clustering method in initially non-diabetic autoantibody-positive relatives of individuals with type 1 diabetes, using the TrialNet Pathway to Prevention study data (n=1123).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!